Sigma Healthcare Ltd (ASX: SIG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Sigma Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Sigma Healthcare Ltd (ASX: SIG)
Latest News
Growth Shares
3 ASX 200 shares I would buy and hold for 10 years
ASX Share Market News
5 things to watch on the ASX 200 on Tuesday
Healthcare Shares
Sigma Healthcare vs Sonic Healthcare: Which ASX healthcare share wins?
ASX Share Market News
ASX 200 healthcare shares lead a weaker market amid 82% chance of a rate hike
Retirement
3 ASX shares I'd buy for income and growth in retirement
Broker Notes
9 ASX 200 shares earning strengthened buy ratings this week
Healthcare Shares
A rare buying opportunity in 1 of Australia's top shares?
Broker Notes
2 ASX shares tipped to return 19% to 47%
Broker Notes
UBS names its 10 top ASX picks for the next 3-6 months
Dividend Investing
Own BHP, Woodside or Coles shares? Here's what investors should know
Investing Strategies
Where I'd invest $20,000 in ASX shares this spring
Broker Notes
Top brokers name 3 ASX shares to buy next week
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 03 Sep 2026 | $0.0200 | 100.00% | Interim | 22 Sep 2026 |
| 04 Mar 2026 | $0.0200 | 100.00% | Final | 20 Mar 2026 |
| 02 Sep 2025 | $0.0130 | 100.00% | Interim | 18 Sep 2025 |
| 01 Oct 2024 | $0.0050 | 0.00% | Interim | 17 Oct 2024 |
| 28 Mar 2024 | $0.0050 | 50.00% | Final | 17 Apr 2024 |
| 25 Sep 2023 | $0.0050 | 100.00% | Interim | 11 Oct 2023 |
| 30 Mar 2023 | $0.0050 | 100.00% | Final | 18 Apr 2023 |
| 29 Sep 2022 | $0.0050 | 100.00% | Interim | 12 Oct 2022 |
| 04 Apr 2022 | $0.0100 | 100.00% | Final | 22 Apr 2022 |
| 24 Sep 2021 | $0.0100 | 100.00% | Interim | 08 Oct 2021 |
| 06 Apr 2021 | $0.0100 | 100.00% | Final | 21 Apr 2021 |
| 19 Sep 2019 | $0.0100 | 100.00% | Interim | 04 Oct 2019 |
| 03 Apr 2019 | $0.0200 | 100.00% | Final | 29 Apr 2019 |
| 12 Oct 2018 | $0.0150 | 100.00% | Interim | 29 Oct 2018 |
| 05 Apr 2018 | $0.0250 | 100.00% | Final | 20 Apr 2018 |
| 19 Sep 2017 | $0.0250 | 100.00% | Interim | 05 Oct 2017 |
| 06 Apr 2017 | $0.0300 | 100.00% | Final | 21 Apr 2017 |
| 20 Sep 2016 | $0.0250 | 100.00% | Interim | 03 Oct 2016 |
| 06 Apr 2016 | $0.0300 | 100.00% | Final | 21 Apr 2016 |
| 03 Apr 2014 | $0.0200 | 100.00% | Final | 30 Apr 2014 |
| 21 Sep 2012 | $0.0200 | 100.00% | Interim | 26 Oct 2012 |
| 05 Apr 2011 | $0.1500 | 100.00% | Special Cash | 11 May 2011 |
| 16 Oct 2009 | $0.0300 | 100.00% | Interim | 13 Nov 2009 |
| 31 Mar 2009 | $0.0400 | 100.00% | Final | 07 May 2009 |
| 30 Sep 2008 | $0.0300 | 100.00% | Interim | 29 Oct 2008 |
| 29 Aug 2005 | $0.0200 | 100.00% | Interim | 15 Sep 2005 |
| 02 Mar 2004 | $0.2000 | 100.00% | Final | 23 Mar 2004 |
SIG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Sigma Healthcare Ltd
Sigma Healthcare Ltd (ASX: SIG) is an Australian pharmaceutical wholesaler and retail pharmacy franchisor. Following its 2025 merger with Chemist Warehouse, Sigma now combines wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies with a large retail network operating under brands including Chemist Warehouse, Amcal, Discount Drug Stores, and My Chemist.
The company also provides dose administration aid services and technology and data analytics solutions to its pharmacy customers. Sigma Healthcare was founded in 1912 and is headquartered in Clayton, Victoria.
SIG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 Oct 2026 | $2.69 | $0.07 | 2.67% | 11,437,917 | $2.63 | $2.70 | $2.62 |
| 08 Oct 2026 | $2.62 | $-0.02 | -0.76% | 15,788,824 | $2.64 | $2.65 | $2.59 |
| 07 Oct 2026 | $2.64 | $0.02 | 0.76% | 25,698,950 | $2.63 | $2.66 | $2.63 |
| 06 Oct 2026 | $2.62 | $0.02 | 0.77% | 10,797,547 | $2.62 | $2.64 | $2.60 |
| 05 Oct 2026 | $2.60 | $0.00 | 0.00% | 8,842,625 | $2.60 | $2.63 | $2.59 |
| 02 Oct 2026 | $2.60 | $0.03 | 1.17% | 9,569,267 | $2.58 | $2.60 | $2.57 |
| 01 Oct 2026 | $2.57 | $-0.02 | -0.77% | 15,688,512 | $2.58 | $2.59 | $2.55 |
| 30 Sep 2026 | $2.59 | $0.03 | 1.17% | 16,571,012 | $2.56 | $2.60 | $2.55 |
| 29 Sep 2026 | $2.56 | $0.00 | 0.00% | 7,738,692 | $2.56 | $2.58 | $2.54 |
| 28 Sep 2026 | $2.56 | $-0.01 | -0.39% | 14,228,539 | $2.55 | $2.57 | $2.55 |
| 25 Sep 2026 | $2.57 | $-0.01 | -0.39% | 12,264,109 | $2.58 | $2.59 | $2.56 |
| 24 Sep 2026 | $2.58 | $0.02 | 0.78% | 14,858,018 | $2.53 | $2.60 | $2.53 |
| 23 Sep 2026 | $2.56 | $0.00 | 0.00% | 12,444,941 | $2.57 | $2.58 | $2.55 |
| 22 Sep 2026 | $2.56 | $0.03 | 1.19% | 9,949,887 | $2.51 | $2.57 | $2.51 |
| 21 Sep 2026 | $2.53 | $-0.02 | -0.78% | 9,543,132 | $2.54 | $2.56 | $2.52 |
| 18 Sep 2026 | $2.55 | $0.05 | 2.00% | 40,248,099 | $2.50 | $2.55 | $2.47 |
| 17 Sep 2026 | $2.50 | $-0.09 | -3.47% | 33,594,477 | $2.59 | $2.62 | $2.50 |
| 16 Sep 2026 | $2.59 | $-0.05 | -1.89% | 31,743,068 | $2.64 | $2.65 | $2.59 |
| 15 Sep 2026 | $2.64 | $0.01 | 0.38% | 22,782,545 | $2.63 | $2.65 | $2.62 |
| 14 Sep 2026 | $2.63 | $0.00 | 0.00% | 24,475,593 | $2.62 | $2.65 | $2.61 |
| 11 Sep 2026 | $2.63 | $-0.01 | -0.38% | 18,156,490 | $2.63 | $2.64 | $2.62 |
| 10 Sep 2026 | $2.64 | $-0.03 | -1.12% | 24,863,126 | $2.65 | $2.66 | $2.64 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 18 Sep 2026 | Mario Verrocchi | Buy | 2,000,000 | $5,092,146 |
On-market trade.
|
| 14 Sep 2026 | Neville Mitchell | Buy | 20,000 | $53,100 |
On-market trade.
|
| 31 Aug 2026 | Vikesh Ramsunder | Issued | 564,896 | $1,519,570 |
Issue of securities. 2,389,068 rights and performance shares
|
| 09 Jan 2026 | Vikesh Ramsunder | Issued | 813,449 | $2,350,867 |
Issue of securities. 1824172 Rights
|
| 09 Jan 2026 | Danielle Di Pilla | Issued | 141,591 | $409,197 |
Issue of securities. 141,591 2025 LTI Rights
|
| 09 Jan 2026 | Mario Verrocchi | Issued | 314,021 | $907,520 |
Issue of securities. 314,021 2025 LTI Rights
|
| 10 Nov 2025 | Annette Carey | Buy | 10,000 | $31,237 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Christopher Graham Roberts | Non-Executive Director | Oct 2023 |
Dr Roberts is the Chair of the Risk, Compliance and Sustainability Committee. He has more than 40 years' experience in the medical device industry, including as the Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a director of ResMed Inc until November 2017. Dr Roberts is currently a Non-Executive Director of Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. Dr Roberts is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
|
| Mr Neville Mitchell | Non-Executive Director | Feb 2023 |
Mr Mitchell is member of the IBC Committee. Mr Mitchell has financial experience coupled with board experience as a Non-Executive Director. He is currently a Non-Executive Director of Sonic Healthcare Limited from September 2017. He is Chair of the Sonic Audit Committee. He has international healthcare and finance experience. Prior to becoming a Non-Executive Director, he had a career spanning 27 years with Cochlear Limited and 22 years as Chief Financial Officer and Company Secretary.
|
| Mr Michael Sammells | Non-Executive DirectorNon-Executive Chairman | Feb 2020 |
Mr Sammells is also the Chair of the Related Party Independent Board Committee (IBC). He is currently a Non-Executive Director at AMP Limited and a director at GMHBA. He has over 35 years of experience in finance, corporate services and has held operational roles with experience in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. He is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
|
| Mr Vikesh Ramsunder | Chief Executive OfficerManaging Director | Feb 2022 |
Mr Ramsunder brings blend of operational leadership, strategic focus, industry and financial acumen. He has experience in wholesaling, logistics, pharmacy and retailing, and was integral to the growth of the Clicks Group which is now one of the pharmacy and retail operations in Africa. Prior to joining Sigma, Mr Ramsunder spent 28 years with the Clicks Group, including 18 years as a member of the executive team. Mr Ramsunder served as Group CEO from January 2019 to December 2021 and previously held senior leadership positions including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesaler business, United Pharmaceutical Distributors from 2010.
|
| Ms Annette May Carey | Non-Executive Director | Apr 2023 |
Ms Carey is member of the IBC and Member of the Risk, Compliance and Sustainability Committee. She is a current Non-Executive Director of Downer EDI Limited, Bapcor Limited and the Kinetic bus group. She was a previous Non-Executive Director of National Intermodal Corporation. She previously held legal roles at two commercial law firms and the Lendlease group before joining Linfox Logistics and progressing from General Counsel and Company Secretary to Chief Executive Officer of Linfox Logistics ANZ and Linfox Armaguard. She also held the position of Executive General Manager International with Australia Post. She has held director roles within the Linfox group of companies and been Chair or Deputy Chair of Australia Post joint ventures in the UK and China. She has a balance of technical experience as well as legal, strategic and commercial intellect from over 30 years' experience in supply chain, logistics, cross border e-commerce and commercial law.
|
| Mr Jack Gance | Non-Executive Director | Feb 2025 |
Mr Gance is member of the Risk, Compliance and Sustainability Committee. He co-founded Chemist Warehouse with Mr S Gance. He was previously Chair of Chemist Warehouse. He opened his first pharmacy store in Reservoir, Victoria, with Mr S Gance in 1972. In 1997, Messrs Gance and Mr Verrocchi, established MyChemist and opened the first MyChemist store. In 2000, they established the Chemist Warehouse chain and opened the first Chemist Warehouse store. Mr Gance also created the brands Le Specs, Le Tan and Colours of Australis.
|
| Ms Danielle Di Pilla | Executive Director | Feb 2025 |
Ms Di Pilla is a Member of the Risk, Compliance and Sustainability Committee. She established DPP Pharmaceuticals Pty Ltd (DPP) in 2000 and is the founder of brands such as Goat Soap, which has had international success. Ms Di Pilla is the Managing Director of DPP since it was incorporated. She also currently sits on the Board of Gotcha4Life.
|
| Mr Mario Verrocchi | Executive Director | Feb 2025 |
Mr Verrocchi is a Member of the Risk, Compliance and Sustainability Committee. He is also the Chief Executive Officer - Retail. He joined Mr J Gance and Mr S Gance's pharmacy group in 1982. He established MyChemist with Messrs Gance in 1997 and subsequently created the Chemist Warehouse chain with Messrs Gance in 2000.
|
| Mr Damien Gance | Executive Director | Feb 2025 |
Mr Gance is a Member of the Risk, Compliance and Sustainability Committee. He joined MyChemist in 1998 and was the first Chemist Warehouse Franchisee opening the first Chemist Warehouse pharmacy in June 2000. He was previously the Chief Strategy and Business Development Officer of the Group.
|
| Ms Kara McGowan | General Counsel Chief Legal OfficerCompany Secretary | Oct 2021 |
-
|
| Kara McGowan | General Counsel Chief Legal OfficerCompany Secretary |
-
|
|
| Richard Murray | CFO |
-
|
|
| Gary Woodford | Other Executive Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mfv Family Foundation Pty Ltd | 2,233,512,925 | 19.35% |
| HSBC Custody Nominees (Australia) Limited | 1,568,948,429 | 13.59% |
| Jeg Family Foundation Pty Ltd | 1,395,930,781 | 12.09% |
| Sg Family Foundation Pty Ltd | 1,301,217,384 | 11.27% |
| Citicorp Nominees Pty Limited | 1,124,032,765 | 9.74% |
| J P Morgan Nominees Australia Pty Limited | 726,155,579 | 6.29% |
| Mjv Family Foundation Pty Ltd | 280,000,000 | 2.43% |
| Av Family Foundation Pty Ltd | 275,524,439 | 2.39% |
| BNP Paribas Noms Pty Ltd | 156,027,444 | 1.35% |
| Mr Sunil Narula | 155,893,114 | 1.35% |
| Dgsr Family Foundation Pty Ltd | 127,329,615 | 1.10% |
| BNP Paribas Nominees Pty Ltd | 92,318,155 | 0.80% |
| Rispin Mott Nominees Pty Ltd | 67,615,674 | 0.59% |
| NMS Nominees Pty Ltd | 65,065,709 | 0.56% |
| NMS Nominees Pty Ltd i | 55,986,218 | 0.48% |
| Citicorp Nominees Pty Limited i | 53,100,179 | 0.46% |
| Mat Family Foundation Pty Ltd | 48,144,781 | 0.42% |
| Invia Custodian Pty Limited | 47,500,000 | 0.41% |
| UBS Nominees Pty Ltd | 47,229,447 | 0.41% |
| Netwealth Investments Limited | 42,696,069 | 0.37% |